167 related articles for article (PubMed ID: 29386580)
1. IL-6 receptor blockade corrects defects of XIAP-deficient regulatory T cells.
Hsieh WC; Hsu TS; Chang YJ; Lai MZ
Nat Commun; 2018 Jan; 9(1):463. PubMed ID: 29386580
[TBL] [Abstract][Full Text] [Related]
2. Intact Regulatory T-Cell Function but Defective Generation of IL-17A-Producing CD4+ T Cells in XIAP Deficiency.
Gurram B; Hammelev E; Syverson G; Haribhai D; Yan K; Simpson P; Salzman N; Verbsky JW
J Pediatr Gastroenterol Nutr; 2016 Aug; 63(2):218-25. PubMed ID: 26825770
[TBL] [Abstract][Full Text] [Related]
3. XIAP deficiency syndrome in humans.
Latour S; Aguilar C
Semin Cell Dev Biol; 2015 Mar; 39():115-23. PubMed ID: 25666262
[TBL] [Abstract][Full Text] [Related]
4. XIAP deficiency in humans causes an X-linked lymphoproliferative syndrome.
Rigaud S; Fondanèche MC; Lambert N; Pasquier B; Mateo V; Soulas P; Galicier L; Le Deist F; Rieux-Laucat F; Revy P; Fischer A; de Saint Basile G; Latour S
Nature; 2006 Nov; 444(7115):110-4. PubMed ID: 17080092
[TBL] [Abstract][Full Text] [Related]
5. SOCS1 Is a Key Molecule That Prevents Regulatory T Cell Plasticity under Inflammatory Conditions.
Takahashi R; Nakatsukasa H; Shiozawa S; Yoshimura A
J Immunol; 2017 Jul; 199(1):149-158. PubMed ID: 28550203
[TBL] [Abstract][Full Text] [Related]
6. IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection.
Berretta F; St-Pierre J; Piccirillo CA; Stevenson MM
J Immunol; 2011 Apr; 186(8):4862-71. PubMed ID: 21389253
[TBL] [Abstract][Full Text] [Related]
7. IFN-γ production by allogeneic Foxp3+ regulatory T cells is essential for preventing experimental graft-versus-host disease.
Koenecke C; Lee CW; Thamm K; Föhse L; Schafferus M; Mittrücker HW; Floess S; Huehn J; Ganser A; Förster R; Prinz I
J Immunol; 2012 Sep; 189(6):2890-6. PubMed ID: 22869903
[TBL] [Abstract][Full Text] [Related]
8. Inability to resolve specific infection generates innate immunodeficiency syndrome in Xiap-/- mice.
Hsieh WC; Chuang YT; Chiang IH; Hsu SC; Miaw SC; Lai MZ
Blood; 2014 Oct; 124(18):2847-57. PubMed ID: 25190756
[TBL] [Abstract][Full Text] [Related]
9. Phenotypic differences between mice deficient in XIAP and SAP, two factors targeted in X-linked lymphoproliferative syndrome (XLP).
Rumble JM; Oetjen KA; Stein PL; Schwartzberg PL; Moore BB; Duckett CS
Cell Immunol; 2009; 259(1):82-9. PubMed ID: 19595300
[TBL] [Abstract][Full Text] [Related]
10. Anti-interleukin 6 receptor antibodies attenuate antibody recall responses in a mouse model of allosensitization.
Kim I; Wu G; Chai NN; Klein AS; Jordan S
Transplantation; 2014 Dec; 98(12):1262-70. PubMed ID: 25286051
[TBL] [Abstract][Full Text] [Related]
11. Interleukin-6 receptor blockade enhances CD39+ regulatory T cell development in rheumatoid arthritis and in experimental arthritis.
Thiolat A; Semerano L; Pers YM; Biton J; Lemeiter D; Portales P; Quentin J; Jorgensen C; Decker P; Boissier MC; Louis-Plence P; Bessis N
Arthritis Rheumatol; 2014 Feb; 66(2):273-83. PubMed ID: 24504799
[TBL] [Abstract][Full Text] [Related]
12. Induced regulatory T cells are phenotypically unstable and do not protect mice from rapidly progressive glomerulonephritis.
Ghali JR; Alikhan MA; Holdsworth SR; Kitching AR
Immunology; 2017 Jan; 150(1):100-114. PubMed ID: 27606831
[TBL] [Abstract][Full Text] [Related]
13. Dysfunction of hepatic regulatory T cells in experimental sclerosing cholangitis is related to IL-12 signaling.
Schwinge D; von Haxthausen F; Quaas A; Carambia A; Otto B; Glaser F; Höh B; Thiele N; Schoknecht T; Huber S; Steffens N; Lohse AW; Herkel J; Schramm C
J Hepatol; 2017 Apr; 66(4):798-805. PubMed ID: 27965154
[TBL] [Abstract][Full Text] [Related]
14. Ablation of peroxiredoxin II attenuates experimental colitis by increasing FoxO1-induced Foxp3+ regulatory T cells.
Won HY; Jang EJ; Lee K; Oh S; Kim HK; Woo HA; Kang SW; Yu DY; Rhee SG; Hwang ES
J Immunol; 2013 Oct; 191(8):4029-37. PubMed ID: 24048895
[TBL] [Abstract][Full Text] [Related]
15. Beta2-adrenergic receptor signaling in CD4+ Foxp3+ regulatory T cells enhances their suppressive function in a PKA-dependent manner.
Guereschi MG; Araujo LP; Maricato JT; Takenaka MC; Nascimento VM; Vivanco BC; Reis VO; Keller AC; Brum PC; Basso AS
Eur J Immunol; 2013 Apr; 43(4):1001-12. PubMed ID: 23436577
[TBL] [Abstract][Full Text] [Related]
16. X-linked inhibitor of apoptosis protein deficiency: more than an X-linked lymphoproliferative syndrome.
Aguilar C; Latour S
J Clin Immunol; 2015 May; 35(4):331-8. PubMed ID: 25737324
[TBL] [Abstract][Full Text] [Related]
17. SOCS1 negatively regulates the production of Foxp3+ CD4+ T cells in the thymus.
Zhan Y; Davey GM; Graham KL; Kiu H; Dudek NL; Kay T; Lew AM
Immunol Cell Biol; 2009; 87(6):473-80. PubMed ID: 19381159
[TBL] [Abstract][Full Text] [Related]
18. E3 Ubiquitin Ligase VHL Regulates Hypoxia-Inducible Factor-1α to Maintain Regulatory T Cell Stability and Suppressive Capacity.
Lee JH; Elly C; Park Y; Liu YC
Immunity; 2015 Jun; 42(6):1062-74. PubMed ID: 26084024
[TBL] [Abstract][Full Text] [Related]
19. CTLA-4 (CD152) blockade does not cause a pro-inflammatory cytokine profile in regulatory T cells.
Kolar P; Hoff H; Maschmeyer P; Burmester GR; Brunner-Weinzierl MC
Clin Exp Rheumatol; 2011; 29(2):254-60. PubMed ID: 21418778
[TBL] [Abstract][Full Text] [Related]
20. Lentiviral Gene Transfer Corrects Immune Abnormalities in XIAP Deficiency.
Topal J; Panchal N; Barroeta A; Roppelt A; Mudde A; Gaspar HB; Thrasher AJ; Houghton BC; Booth C
J Clin Immunol; 2023 Feb; 43(2):440-451. PubMed ID: 36329240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
